Effects of multidisciplinary collaborative nursing combined with cognitive stimulation therapy on cognitive function, quality of life, and daily activities in patients with Alzheimer’s disease
Main Article Content
Keywords
Canadian; , diagnostic assessment; , Fetal Alcohol Spectrum Disorder (FASD)
Abstract
Alzheimer’s disease (AD) is a neurodegenerative condition that disrupts neuropsychological activity and hinders the development of mental capacity. Efficient AD therapy is a major challenge in biological studies. Alzheimer’s condition cannot be cured with any particular medication. The purpose of this study is to investigate the impact of multidisciplinary collaborative nursing and cognitive stimulation therapy (MCN-CST) on daily activities, quality of life, and cognitive performance in AD patients. The inclusion/exclusion method is initially used to gather information about AD patients. Control and investigative teams were formed with its own set of functions. The control group gets a regular course of treatment, whereas, the investigation group receives MCN-CST. To ensure that our study is as practical and useful, we compare our findings to existing nursing approaches. The ANOVA and Chi-Square tests are used to assess the condi-tions of Alzheimer’s patients. There was a scientifically significant improvement in the overall level of their medical condition after implementing MCN-CST. Nursing protocols developed MCN-CST is beneficial in improving patients’ quality of life, cognitive function, and daily activities. It is encouraged to do intensive research using many samples drawn from a wider range of people.
References
2. Mody RN, Bhoosreddy AR. Multiple odontogenic keratocyst: a case report. Ann Dent. 1995;54(1–2):41–43.
3. Garg H. Digital twin technology: revolutionary to improve personalized healthcare. Sci Prog Res. 2021;1:32–34.
4. Dhapola R, Hota SS, Sarma P, Bhattacharyya A, Medhi B, Reddy DH. Recent advances in molecu-lar pathways and therapeutic implications target-ing neuroinflammation for Alzheimer’s disease. Inflammopharmacology. 2021;29:1–13.
5. Ahmed B, Ali A. Usage of traditional Chinese medicine, western medicine and integrated chinese-western medicine for the treatment of allergic rhi-nitis. Sci Prog Res. 2020;1:1–9.
6. Abdalrahim A, ALBashtawy M, Alkhawaldeh A, Al-Amer RM, Salameh AB, Khait AA, et al. An analysis of nursing and medical students’ attitudes towards and knowledge of Alzheimer’s Disease (AD). Int J Nurs Educ Scholarsh. 2022;19(1):20220033. https://doi.org/10.1515/ijnes-2022-0033
7. Cafferata RM, Hicks B, von Bastian CC. Effectiveness of cognitive stimulation for dementia: a systematic review and meta-analysis. Psychol Bull. 2021;147(5):455. https://doi.org/10.1037/bul0000325
8. Mukhopadhyay S, Banerjee D. A primer on the evolution of Aducanumab: the first antibody approved for the treatment of Alzheimer’s disease. J Alzheimer’s Dis. 2021;83(4):1537–52. https://doi.org/10.3233/JAD-215065
9. Shahabaz A, Afzal M. Implementation of high dose rate brachytherapy in cancer treatment. Sci Prog Res. 2021;1:77–106. https://doi.org/10.52152/spr/2021.121
10.Chung M, Rhee HY, Chung WK. Clinical approach of low-dose whole-brain ionizing radiation treat-ment in Alzheimer’s disease dementia patients. J Alzheimer’s Dis. 2021;80(3):941–7. https://doi.org/10.3233/JAD-210042
11.Park SH, Baik K, Jeon S, Chang WS, Ye BS, Chang JW. Extensive frontal focused ultrasound-mediated blood-brain barrier opening for the treat-ment of Alzheimer’s disease: a proof-of-concept study. Transl Neurodegener. 2021;10(1):1–11. https://doi.org/10.1186/s40035-021-00269-8
12.Theofanidis D, Fountouki A, Kotrotsiou S. Nursing interventions in Alzheimer’s disease: a concise practical guide for everyday use. Int J Caring Sci. 2021;14(1):106–14.
13.Wu H, Wen Y, Guo S. Role of nutritional sup-port under clinical nursing path on the efficacy, quality of life, and nutritional status of elderly patients with Alzheimer’s disease. Evid-Based Complementary Altern Med. 2022;2022:6. https://doi.org/10.1155/2022/9712330
14.Liu XY, Yang LP, Zhao L. Stem cell therapy for Alzheimer’s disease. World J Stem Cells. 2020;12(8):787. https://doi.org/10.4252/wjsc.v12.i8.787
15.Zihan L. Treatment and technology of domestic sewage for improvement of rural environment in China-Jiangsu: a research. Sci Prog Res. 2022;2; 2(2):466–475. https://doi.org/10.52152/spr/2021.168
16.Lilamand M, Mouton-Liger F, Paquet C. Ketogenic diet therapy in Alzheimer’s disease: an updated review. Curr Opin Clin Nutr Metab Care. 2021;24(4):372–8. https://doi.org/10.1097/MCO.0000000000000759
17.Salihu SO, Iyya Z. Assessment of Physicochemical parameters and Organochlorine pesticide residues in selected vegetable farmlands soil in Zamfara State, Nigeria. Sci Prog Res. 2022;2:559–66. https://doi.org/10.52152/spr/2022.171
18.Qiao YC, Chang H, Wang R, Wang JM, Wang XY, Yu Y, et al. Individual cognitive stimulation therapy in Alzheimer’s disease: a randomized controlled trial. 2021. [Preprint]. https://doi.org/10.21203/rs.3.rs-138365/v1
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.